ScottySkis
Well-known member
- Joined
- Jul 23, 2020
Huntington D Trials postive news below:
BREAKING NEWS
uniQure shared news today that the first European patients were dosed in their open-label study of AMT-130, a huntingtin-lowering gene therapy. Safety data from the first group of 10 participants in the USA is expected in the second quarter of 2022.
READ FULL PRESS RELEASE: https://tools.eurolandir.com/tools/.../?ID=4040264&lang=en-GB&companycode=nl-qure&v
#HuntingtonsDisease #LetsTalkAboutHD #HDSAFamily
BREAKING NEWS
uniQure shared news today that the first European patients were dosed in their open-label study of AMT-130, a huntingtin-lowering gene therapy. Safety data from the first group of 10 participants in the USA is expected in the second quarter of 2022.
READ FULL PRESS RELEASE: https://tools.eurolandir.com/tools/.../?ID=4040264&lang=en-GB&companycode=nl-qure&v
#HuntingtonsDisease #LetsTalkAboutHD #HDSAFamily